Please login to the form below

Not currently logged in
Email:
Password:

Nycomed markets Bonviva drug in Asia

Nycomed has become marketing authorisation holder of osteoporosis treatment Bonviva in key Asia-Pacific countries

Nycomed has completed the transfer of marketing authorisation approval for osteoporosis treatment Bonviva (Ibandronate) in a number of key Asia Pacific markets.

The licensing and supply agreement with Roche covers China, Hong Kong, Malaysia, Australia, New Zealand, Philippines, Singapore, Taiwan and Vietnam, with a future option to commercialise Bonviva in additional Asia Pacific territories.

Under the terms of the deal, Nycomed will hold marketing authorisation holder in all the licensed territories. Bonviva is a bisphosphonate used in the treatment of osteoporosis in post-menopausal women.

Financial details of the agreement were not disclosed.

Guido Oelkers, executive vice-president of commercial operations, said: "The in-licensing of Bonviva from Roche is another important step towards Nycomed's expansion in the Asia Pacific region and demonstrates our growing attraction as a marketing partner for leading companies and brands in these dynamic countries.”

Nycomed recently opened offices in China, South Korea, Indonesia, Malaysia and the Philippines.

15th June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics